Menu

Department of Military Affairs Tender by Indian Air Force (GEM/2025/B/6107603)

HUMAN PAPILOMA VIRUS QUADRIVALENT (TYPES 6, 11, 6 & 18) VACCINES PFS OF 0.5ML

Goods
Qty:200
Department of Military Affairs Tender by Indian Air Force (GEM/2025/B/6107603)

Tender Timeline

Tender Issue
April 25, 2025 at 1:11 PM

Tender Title: Supply of Human Papilloma Virus Quadrivalent Vaccines
Reference Number: GEM/2025/B/6107603
Issuing Authority/Department: Department of Military Affairs, Ministry of Defence

The Department of Military Affairs under the Ministry of Defence invites tenders for the supply of Human Papilloma Virus Quadrivalent Vaccines (Types 6, 11, 16 & 18) in single-use prefilled syringes of 0.5 ml. This tender aims to enhance public health by ensuring wider availability of these vital vaccines, which are crucial in preventing specific types of cancers associated with the human papillomavirus.

Scope of Work and Objectives

The selected vendor will be responsible for the supply of a total of 200 doses of the HPV quadrivalent vaccines. This contract focuses on delivering high-quality vaccines conforming to specified health standards. The main objectives include:

  • Ensuring timely delivery and adherence to quality specifications.
  • Upholding appropriate storage conditions during transportation to maintain efficacy.
  • Implementing effective tracking and reporting of the supplied vaccines.

Eligibility Criteria

To be eligible for this tender, participants must meet certain eligibility requirements, including:

  • Being a registered entity with the required health regulatory approvals.
  • Having experience in the pharmaceutical industry, preferably with previous contracts involving vaccine supply.
  • Compliance with Good Manufacturing Practices (GMP) and other relevant local regulations.

Technical Requirements

The technical specifications are as follows:

  • Form of the vaccine: Quadrivalent (Types 6, 11, 16 & 18) in prefilled syringes.
  • Dosage form: 0.5 ml per dose.
  • Must comply with WHO and local regulations concerning vaccine production and distribution.
  • Detailed data regarding storage conditions, shelf life, and efficacy must be included in the proposal.

Financial Requirements

Bidders must submit financial statements demonstrating their capacity to undertake the contract. Payment terms will be outlined in the final agreement post-selection, ensuring compliance with relevant financial regulations. An Earnest Money Deposit (EMD) may be applicable as part of the submission.

Document Submission Details

Interested vendors are required to submit their proposals electronically through the designated platform. Complete submissions must include:

  • Certification evidencing adherence to relevant health regulations.
  • A detailed proposal outlining compliance with technical and quality standards.
  • Financial documentation as per the eligibility criteria.

Special Provisions

This tender encourages Micro, Small, and Medium Enterprises (MSEs) and startups by providing preferential treatment in the evaluation process. Specific guidelines regarding the local content and procurement policies will be applicable, affirming a commitment to local manufacturing initiatives.

Evaluation Process

Proposals will be evaluated based on technical merit, compliance with specifications, and financial viability. The evaluation committee will assess the documentation thoroughly to ensure that all criteria are met.

Delivery Locations

The delivery of the vaccines should be precise and timely, with further details specified upon awarding of the contract, ensuring alignment with health distribution guidelines.

Contact Information

For any inquiries regarding the tender specifications or submission process, please refer to the official contact channels provided in the tender documentation.

By supplying these vaccines, the winning bidder will play a critical role in enhancing healthcare outcomes, thereby contributing to the broader public health objectives of the Ministry of Defence.


General Information

Item Category
HUMAN PAPILOMA VIRUS QUADRIVALENT (TYPES 6, 11, 6 & 18) VACCINES PFS OF 0.5ML
Ministry Name
Organisation Name

Financial Information

Bid Offer Validity
90 (Days)
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Total value wise evaluation
Inspection Required
Yes
Technical Clarifications Time
2 Days

Tender Documents

3 Documents
GeM-Bidding-7703850.pdfMain Document
Other DocumentsOTHER
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Documents Required from Seller

  • Experience Criteria
  • Certificate (Requested in ATC)
  • OEM Authorization Certificate
  • Additional Doc 1 (Requested in ATC) *In case any bidder is seeking exemption from Experience / Turnover Criteria
  • the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Frequently Asked Questions

The eligibility requirements for this tender include being a registered entity with the necessary health regulatory approvals. Participating vendors must demonstrate prior experience in vaccine supply, adhere to Good Manufacturing Practices (GMP), and comply with relevant local and international health regulations. Providing proof of past performance in similar projects is advised to enhance the proposal’s credibility.

The technical specifications for the Human Papilloma Virus Quadrivalent Vaccines include being in a dosage form of 0.5 ml per dose and packaged in prefilled syringes. Compliance with WHO standards and local manufacturing regulations is essential. Bidders must provide detailed information regarding the vaccines’ efficacy, storage conditions, and shelf life in their proposals.

Yes, this tender provides incentives for Micro, Small, and Medium Enterprises (MSEs) and startups. These entities may receive preferential treatment during the evaluation process, enhancing their chances of selection. All qualifying businesses should ensure they highlight their MSE or startup status in their proposals to take advantage of these benefits.

The evaluation and selection process will be based on a comprehensive review of submitted proposals, focusing on technical compliance, financial viability, and past performance. The evaluation committee will use a structured methodology to ensure that all submissions are assessed uniformly and transparently, leading to the selection of the most qualified supplier for the contract.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders